BIOMAT Database Logo BIOMAT Database Logo

Prostate cancer: loss of PTEN promotes progression of prostate cancer in an androgen-independent manner. 2011

Nick Warde

UI MeSH Term Description Entries

Related Publications

Nick Warde
Conditional Akt activation promotes androgen-independent progression of prostate cancer.
March 2007, Carcinogenesis,
Nick Warde
PTEN and GSK3beta: key regulators of progression to androgen-independent prostate cancer.
January 2006, Oncogene,
Nick Warde
Loss of Ceacam1 promotes prostate cancer progression in Pten haploinsufficient male mice.
June 2020, Metabolism: clinical and experimental,
Nick Warde
Androgen receptor promotes ligand-independent prostate cancer progression through c-Myc upregulation.
January 2013, PloS one,
Nick Warde
Pten inactivation and the emergence of androgen-independent prostate cancer.
July 2007, Cancer research,
Nick Warde
[Mechanism on androgen-independent progression of prostate cancer].
May 1997, Nihon rinsho. Japanese journal of clinical medicine,
Nick Warde
Neutral endopeptidase 24.11 loss in metastatic human prostate cancer contributes to androgen-independent progression.
January 1998, Nature medicine,
Nick Warde
Androgen-independent prostate cancer progression in the TRAMP model.
November 1997, Cancer research,
Nick Warde
Prostate cancer: PTEN loss and PSGR overexpression promote cancer progression.
July 2015, Nature reviews. Urology,
Nick Warde
Protocadherin-PC promotes androgen-independent prostate cancer cell growth.
July 2006, The Prostate,
Copied contents to your clipboard!